In preclinical studies, supraphysiologic concentrations of T3 are required at the thyroid hormone analogue receptor on integrin αvβ3 in cells from various types of solid tumors to reproduce actions of T4 at physiological concentrations on cell proliferation, migration and tumor-linked angiogenesis (2, 3). This evidence concerns the gene CD4 and neoplasm.